Robert A. Moran

Robert A. Moran

Auto-generated profile, based on publicly available information

Robert A. Moran

School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
PBPhilip Babij
Philip Babij
WZWeiguang Zhao
Weiguang Zhao
CSClayton Small
Clayton Small
YKYogendra Kharode
Yogendra Kharode
PYPaul J Yaworsky
Paul J Yaworsky
FBFrederick Bex
Frederick Bex
A unique mutation in LRP5 is associated with high bone mass in man. Transgenic mice expressing this LRP5 mutation have a similar phenotype with high bone mass and enhanced strength. These results underscore the importance of LRP5 in skeletal regulation and suggest targets for therapies for bone disease. A mutation (G171V) in the low-density lipoprotein receptor related protein 5 (LRP5) has been associated with high bone mass (HBM) in two independent human kindreds. To validate the role of the mutation, several lines of transgenic mice were created expressing either the human LRP5 G171V substitution or the wildtype LRP5 gene in bone. Volumetric bone mineral density (vBMD) analysis by pQCT showed dramatic increases in both total vBMD (30-55%) and trabecular vBMD (103-250%) of the distal femoral metaphysis and increased cortical size of the femoral diaphysis in mutant G171V transgenics at 5, 9, 17, 26, and 52 weeks of age (p < 0.01 for all). In addition, high-resolution microcomputed tomography (microCT) analysis of the distal femorae and lumbar vertebrae revealed an increase (110-232%) in trabecular bone volume fraction caused by both increased trabecular number (41-74%) and increased trabecular thickness (34-46%; p < 0.01 for all) in the mutant G171V mice. The increased bone mass was associated with significant increases in vertebral compressive strength (80-140%) and the increased cortical size with significant increases in femoral bending strength (50-130%). There were no differences in osteoclast number at 17 weeks of age. However, compared with littermate controls, the mutant G171V transgenic mice showed an increase in actively mineralizing bone surface, enhanced alkaline phosphatase staining in osteoblasts, and a significant reduction in the number of TUNEL-positive osteoblasts and osteocytes. These results suggest that the increased bone mineral density in mutant G171V mice was caused by increased numbers of active osteoblasts, which could in part be because of their increased functional lifespan. While slight bone anabolic activity was observed from overexpression of the wildtype LRP5 gene, it is clear that the G171V mutation, rather than overexpression of the receptor itself, is primarily responsible for the dramatic HBM bone effects. Together, these findings establish the importance of this novel and unexpected role of a lipoprotein receptor in regulating bone mass and afford a new model to explore LRP5 and its recent association with Wnt signaling in bone biology.


29 May 2024 in mSphere
Verified
Journal Article
Open access
EDElizabeth M. Darby
Elizabeth M. Darby
RMRobert A. Moran
Robert A. Moran
EHEmma Holden
Emma Holden
TMTheresa Morris
Theresa Morris
FHFreya Harrison
Freya Harrison
JBJessica Blair
Jessica Blair
The two species that account for most cases of Acinetobacter -associated bacteremia in the United Kingdom are Acinetobacter lwoffii , often a commensal but also an emerging pathogen, and Acinetobacter baumannii , a well-known antibiotic-resistant species. While these species both cause similar types of human infection and occupy the same niche, A. lwoffii (unlike A. baumannii ) has thus far remained susceptible to antibiotics. Comparatively little is known about the biology of A. lwoffii , and this is the largest study on it conducted to date, providing valuable insights into its behaviour and potential threat to human health. This study aimed to explain the antibiotic susceptibility, virulence, and fundamental biological differences between these two species. The relative susceptibility of A. lwoffii was explained as it encoded fewer antibiotic resistance and efflux pump genes than A. baumannii (9 and 30, respectively). While both species had markers of horizontal gene transfer, A. lwoffii encoded more DNA defense systems and harbored a far more restricted range of plasmids. Furthermore, A. lwoffii displayed a reduced ability to select for antibiotic resistance mutations, form biofilm, and infect both in vivo and in in vitro models of infection. This study suggests that the emerging pathogen A. lwoffii has remained susceptible to antibiotics because mechanisms exist to make it highly selective about the DNA it acquires, and we hypothesize that the fact that it only harbors a single RND system restricts the ability to select for resistance mutations. This provides valuable insights into how development of resistance can be constrained in Gram-negative bacteria. IMPORTANCE: Acinetobacter lwoffii is often a harmless commensal but is also an emerging pathogen and is the most common cause of Acinetobacter -derived bloodstream infections in England and Wales. In contrast to the well-studied and often highly drug-resistant A. baumannii , A. lwoffii has remained susceptible to antibiotics. This study explains why this organism has not evolved resistance to antibiotics. These new insights are important to understand why and how some species develop antibiotic resistance, while others do not, and could inform future novel treatment strategies.

1 November 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MSMengxiao Shi
Mengxiao Shi
BSBarbara Stauffer
Barbara Stauffer
RBRamesh Bhat
Ramesh Bhat
JBJulia Billiard
Julia Billiard
HPHelga Ponce-De-Leon
Helga Ponce-De-Leon
AGAriamala Gopalsamy
Ariamala Gopalsamy

1 March 2019 in Plasmid
Verified
Journal Article
Closed access
RMRobert A. Moran
Robert A. Moran
IRIsabella A. Richardson
Isabella A. Richardson
RHRuth M. Hall
Ruth M. Hall

1 March 2019 in Plasmid
Verified
Journal Article
Closed access
RMRobert A. Moran
Robert A. Moran
SASashindran Anantham
Sashindran Anantham
RHRuth M. Hall
Ruth M. Hall